Then, Endo et al constructed a model using TBS, AFP, neutrophil-lymphocyte ratio, albumin, gamma-glutamyl transpeptides and vascular involvement, and found that the model was more effective than BCLC in predicting 5-year OS in HCC patients [33]. The gene discussed is AFP; the disease is hepatocellular carcinoma.